Order results by:
| Issue | Title | |
| Vol 8, No 1 (2012) | PRIMARY PREVENTION OF DIABETES MELLITUS: CORRECTION OF EARLY DISORDERS OF GLUCOSE METABOLISM IN CARDIOLOGY PRACTICE | Abstract similar documents |
| M. N. Mamedov, E. A. Poddubskaya, M. N. Kovrigina, Z. O. Ugurchieva, R. T. Digigova | ||
| "... to prevention of type 2 diabetes mellitus (DM). Data of international clinical trials shows that early GMD ..." | ||
| Vol 13, No 1 (2017) | COMPARISON OF EFFECTIVENESS OF ANTIARRHYTHMIC THERAPIES IN POSTOPERATIVE PERIOD OF PULMONARY VEIN OSTIA CATHETER ISOLATION FOR PREVENTION OF EARLY RECURRENCES OF ATRIAL TACHYARRHYTHMIAS IN THE PROOF STUDY | Abstract similar documents |
| A. V. Tarasov, K. V. Davtyan, S. Yu. Martsevich | ||
| "... for the prevention of recurrence of atrial fibrillation (AF) and other atrial tachyarrhythmias in the early ..." | ||
| Vol 8, No 4 (2012) | UP TO DAY POSSIBILITIES OF ATRIAL FIBRILLATION PREVENTION | Abstract similar documents |
| E. A. Protasova, N. V. Furman, O. V. Reshet'ko | ||
| "... and clinical studies show that the use of these drugs may be useful for AF primary prevention in certain ..." | ||
| Vol 16, No 5 (2020) | Possible Approaches to Primary Prevention of Cardiovascular Diseases | Abstract similar documents |
| V. N. Larina, D. S. Mkrtychev, V. A. Kuznetsova, A. A. Tyazhelnikov | ||
| "... , primary prevention of diseases. However, in most cases, patients seek help from a doctor after ..." | ||
| Vol 8, No 4 (2012) | UP TO DATE STATINS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES | Abstract similar documents |
| N. F. Puchin'yan, Ya. P. Dovgalevskiy, A. V. Panina | ||
| "... Early and aggressive treatment of patients with risk factors and clinically manifest ..." | ||
| Vol 12, No 5 (2016) | Statins in Secondary Prevention of Atrial Fibrillation | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova, R. G. Gataulin | ||
| Vol 1, No 2 (2005) | STATINES IN PREVENTION AND TREATMENT OF ATHEROSCLEROSIS CONNECTED DISEASES: EFFICIENCY AND SAFETY | Abstract similar documents |
| Y. A. Karpov | ||
| "... of statines efficiency in prevention of ischemic heart disease (IHD), are analyzed. Decrease in risks ..." | ||
| Vol 14, No 3 (2018) | CARDIOPROTECTIVE PROPERTIES OF LISINOPRIL: NEW POSSIBILITIES | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova, R. G. Gataulin | ||
| "... prevention of arrhythmia in hypertensive patients. ..." | ||
| Vol 14, No 4 (2018) | Differences in the Incidence of Major Risk Factors in Patients with Ischemic or Hemorrhagic Stroke in the Siberian Population | Abstract similar documents |
| S. Yu. Nikulina, A. A. Chernova, D. A. Nikulin, V. A. Shulman, S. V. Prokopenko, I. M. Platunova, O. V. Marilovceva, I. I. Lebedeva, A. A. Semenchukov, D. A. Yakovleva, V. N. Maksimov, A. V. Kuskaeva | ||
| "... prevention of this disease remains relevant. There are modifiable and non-modifiable RF. Aim. To study ..." | ||
| Vol 7, No 3 (2011) | STROKE PREVENTION IN INTERNIST PRACTICE | Abstract similar documents |
| D. A. Napalkov, A. V. Zhilenko | ||
| "... Stroke secondary prevention in internist practice is discussed in accordance with up to date ..." | ||
| Vol 9, No 4 (2013) | STATINS IN PREVENTION OF ISCHEMIC STROKE | Abstract similar documents |
| A. V. Susekov, A. B. Blohin, Z. G. Luginova, E. J. Soloveva, N. V. Maltseva, O. E. Tarasova, V. V. Kuharchuk | ||
| "... The evidence base of statin therapy in primary and secondary prevention of ischemic stroke ..." | ||
| Vol 2, No 2 (2006) | STROKE PREVENTION IN HYPERTENSIVE PATIENTS | Abstract similar documents |
| S. Y. Martsevich, V. A. Egorov | ||
| "... of primary and secondary stroke prevention are discussed. ..." | ||
| Vol 5, No 4 (2009) | PRIMARY PREVENTION OF CARDIOVASCULAR COMPLICATIONS: VALUE OF STATINS | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko | ||
| "... The definition of primary prevention of cardiovascular diseases is presented. Statins preventive ..." | ||
| Vol 9, No 4 (2013) | ACETYLSALICYLIC ACID: CONTROVERSIAL AND OUTSTANDING ISSUES | Abstract similar documents |
| E. N. Dankovtseva | ||
| "... Review of current ideas about the role of acetylsalicylic acid (ASA) in the primary prevention ..." | ||
| Vol 14, No 6 (2018) | Correction of Hypercholesterolemia in Primary and Secondary Prevention of Cardiovascular Diseases: Features and Controversial Issues | Abstract PDF (Eng) similar documents |
| N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan | ||
| "... attention is paid to the use of statins in the primary prevention of cardiovascular complications ..." | ||
| Vol 10, No 2 (2014) | PUBLIC HEALTH: FOCUS ON THE PREVENTION | Abstract similar documents |
| P. Puska, N. V. Dolgushina | ||
| Vol 8, No 2 (2012) | ACETYLSALICYLIC ACID IN THE PREVENTION OF ATHEROTHROMBOTIC EVENTS | Abstract similar documents |
| A. V. Govorin, A. P. Filev | ||
| "... of acetylsalicylic acid (ASA) in primary and secondary prevention of atherothrombotic events. Studies on the safety ..." | ||
| Vol 16, No 3 (2020) | On the Quality of Medical Examination: Diagnostic Significance of the Survey Method for Detecting the Probability of Cardio-Cerebral Symptoms | Abstract similar documents |
| A. M. Kalinina, K. A. Antonov, B. E. Gornyi, I. I. Dubovoj, O. M. Drapkina | ||
| "... .5% it was detected for the first time, i.e. cases of early detection made up the majority (69.2%). The proportion ..." | ||
| Vol 14, No 1 (2018) | IDENTIFICATION OF PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA IN THE RUSSIAN POPULATION USING THE EXAMPLE OF MOSCOW CITY AND MOSCOW REGION | Abstract similar documents |
| I. V. Sergienko, A. A. Ansheles | ||
| "... . This leads to early manifestations of atherosclerosis, including characteristic progressive impairments ..." | ||
| Vol 4, No 3 (2008) | OMEGA-3 POLYUNSATURATED FATTY ACIDS IN ATRIAL FIBRILLATION PREVENTION AFTER SURGICAL MYOCARDIAL REVASCULARIZATION | Abstract similar documents |
| A. V. Panov, B. A. Tatarskiy, M. L. Gordeev, R. I. Nilk | ||
| "... in early postoperative period (24-36 hours after surgery) and lasted next 14 days. Efficacy of the therapy ..." | ||
| Vol 17, No 3 (2021) | Treatment and Secondary Prevention of Venous Thromboembolism in Real Clinical Practice Based on Health Care Professional Survey | Abstract similar documents |
| K. V. Lobastov, A. R. Navasardyan, I. V. Schastlivtsev | ||
| Vol 8, No 6 (2012) | HOW TO USE DABIGATRAN IN PATIENTS WITH ATRIAL FIBRILLATION | Abstract similar documents |
| S. V. Moiseev | ||
| "... clinical trial dabigatran 150 mg b.i.d was more effective than warfarin in prevention of ischemic stroke ..." | ||
| Vol 5, No 6 (2009) | STATIN GENERICS: EFFICACY AND SAFETY RATIO | Abstract similar documents |
| V. P. Voronina, A. A. Serazhim, A. V. Zagrebelnyi, S. Yu. Martsevich, S. A. Shalnova | ||
| "... Statin usage for primary and secondary prevention of cardiovascular diseases is focused. Rational ..." | ||
| Vol 6, No 4 (2010) | ANTITHROMBOTIC THERAPY IN NONVALVULAR ATRIAL FIBRILLATION: PROBLEMS AND PROSPECTS | Abstract similar documents |
| A. Y. Rychkov, N. Y. Khor'kova, A. A. Bliznyakov | ||
| Vol 10, No 2 (2014) | SECONDARY PREVENTION OF STROKE IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: THE CLINICIANS’ VIEWPOINT | Abstract similar documents |
| E. A. Drozdova | ||
| "... of the management of patients with stroke due to non-valvular atrial fibrillation and secondary stroke prevention ..." | ||
| Vol 11, No 1 (2015) | VASCULAR COMORBIDITY: GENERAL APPROACHES TO PREVENTION AND TREATMENT | Abstract PDF (Eng) similar documents |
| R. G. Oganov | ||
| "... on the cardiovascular risk, general causes and approaches to the prevention and treatment of vascular comorbidity ..." | ||
| Vol 8, No 4 (2012) | ACETYLSALICYLIC ACID: WHAT'S NEW IN THE OLD DRUG? | Abstract similar documents |
| I. V. Zhirov | ||
| "... to the cancer prevention. This ASA indication should be confirmed in additional studies. ..." | ||
| Vol 14, No 2 (2018) | WHAT DO PATIENTS WITH ATRIAL FIBRILLATION KNOW ABOUT STROKE AND SYSTEMIC EMBOLISM PREVENTION? DATA OF THE PRIMA-TERRA REGISTRY | Abstract similar documents |
| R. М. Linchak, O. G. Kompaniyets, A. M. Nedbaykin | ||
| "... prevention. Material and methods. This study based on the questionnaire survey of 544 patients from three ..." | ||
| Vol 14, No 2 (2018) | DOCTOR’S ADHERENCE TO RECOMMENDATIONS GOVERNING THE ANTIPLATELET AGENTS USE IN THE CARDIOVASCULAR DISEASES PREVENTION AND TREATMENT | Abstract similar documents |
| N. В. Perepech, A. V. Tregubov | ||
| "... for primary and secondary prevention of cardiovascular diseases. 276 questionnaires filled out by 185 ..." | ||
| Vol 17, No 5 (2021) | Social Network-Based Digital Stroke Prevention: Opportunities, Results and Prospects | Abstract PDF (Eng) similar documents |
| A. E. Demkina, M. V. Bezzubtseva, M. N. Ryabinina, Ya. A. Kotlyar, O. L. Keln, А. V. Sarapulova, R. R. Zhetishev, V. S. Kuvaev, M. Y. Maksimova, N. V. Pogosova, I. V. Zhetisheva | ||
| "... , which is aimed at improving programs for primary and secondary stroke prevention in young people ..." | ||
| Vol 5, No 4 (2009) | PREVENTION OF LEFT VENTRICLE SYSTOLIC DYSFUNCTION IN PATIENTS WITH ACUTE CORONARY SYNDROME WITH ST SEGMENT ELEVATION AFTER CARDIAC REVASCULARIZATION | Abstract similar documents |
| A. L. Alyavi, B. A. Alyavi, M. L. Kenzhaev, S. R. Kenzhaev | ||
| "... of group B in comparison with patients of group A. Conclusion. The early corvitin prescribing has positive ..." | ||
| Vol 17, No 1 (2021) | Myocardial Infarction Complicated by Ischemic Stroke: Risk Factors, Prognosis, Unresolved Problems and Possible Methods of Prevention | Abstract similar documents |
| M. V. Zykov, V. V. Butsev, R. R. Suleymanov | ||
| "... that although stroke is a relatively rare complication of myocardial infarction, its prevention is an extremely ..." | ||
| Vol 8, No 6 (2012) | ASSESSMENT OF DIABETES RISK IN MEN WITH DIFFERENT LEVELS OF CARDIOVASCULAR RISK | Abstract similar documents |
| M. N. Kovrigina, M. N. Mamedov | ||
| "... of DM2 (according to FINDRISC questionnaire). Detection of early markers of glucose metabolism ..." | ||
| Vol 16, No 3 (2020) | Possibilities of Pulse Wave Contour Analysis in Diagnostics of Early Vascular Aging | Abstract similar documents |
| A. M. Tuktarov, A. E. Filippov, A. A. Obrezan, L. V. Kukol' | ||
| "... , arterial age and early vascular aging (EVA) in healthy individuals and patients with cardiovascular risk ..." | ||
| Vol 10, No 1 (2014) | MULTIFACTOR PRIMARY PREVENTION OF ISCHEMIC HEART DISEASE IN MIDDLE-AGED MEN AND ITS EFFICACY (10-YEAR FOLLOW-UP) | Abstract PDF (Eng) similar documents |
| A. M. Kalinina | ||
| "... the efficacy of multifactor primary prevention. Material and methods. The analysis was based on the results ..." | ||
| Vol 1, No 3 (2005) | EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE | Abstract similar documents |
| G. De Backer, E. Ambrosioni, K. Borch-Johnsen, C. Brotons, R. Cifkova, J. Dallongeville, S. Ebrahim, O. Faergeman, I. Graham, G. Mancia, V. Manger Cats, K. Orth-Gomer, J. Perk, K. Pyorala, J. Rodicio, S. Sans, V. Sansoy, U. Sechtem, S. Silber, T. Thomsen, D. Wood | ||
| "... European guidelines on cardiovascular disease prevention in clinical practice. ..." | ||
| Vol 8, No 3 (2012) | RIVAROXABAN IN THE PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH ATRIAL FIBRILLATION | Abstract similar documents |
| M. Yu. Gilyarov | ||
| Vol 19, No 3 (2023) | Nutraceutical support in the prevention and treatment of cardiovascular diseases | Abstract similar documents |
| E. V. Gracheva, E. A. Starovoytova, E. S. Kulikov, N. A. Kirillova, S. V. Fedosenko, M. A. Balaganskaya, D. V. Kromka | ||
| "... , there is a need to find and implement effective methods for the prevention and treatment of such diseases ..." | ||
| Vol 21, No 1 (2025) | The no-reflow phenomenon: current treatment and prevention strategies | Abstract similar documents |
| S. V. Dil, E. V. Vyshlov, M. A. Kercheva, L. N. Maslov, V. V. Ryabov | ||
| "... prevention strategies. Preventive measures include prolonged stent ballooning, antithrombotic agents (e. g ..." | ||
| Vol 18, No 6 (2022) | Acute Coronary Syndrome after Percutaneous Coronary Intervention: State of the Problem and Clinical Practice Data | Abstract similar documents |
| I. S. Egorova, N. N. Vezikova | ||
| "... вторичной профилактики следует отметить недостижение целевых показателей липидного спектра. ..." | ||
| Vol 8, No 6 (2012) | SECONDARY PHARMACOLOGICAL PREVENTION OF CARDIOVASCULAR DISEASES: OUR ABILITY IN CLINICAL PRACTICE | Abstract similar documents |
| E. V. Filippov, S. S. Yakushin | ||
| "... The most pressing issues of the secondary drug prevention of the most common cardiovascular ..." | ||
| Vol 13, No 2 (2017) | SECONDARY PREVENTION IN PATIENTS AFTER MYOCARDIAL INFARCTION AT AMBULATORY SPECIALIZED CARDIOLOGY INSTITUTION (PHARMACOEPIDEMIOLOGY STUDY) | Abstract similar documents |
| S. B. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, D. A. Dimitrova | ||
| "... prevention of cardiovascular diseases in patients with a history of myocardial infarction in ambulatory ..." | ||
| Vol 13, No 2 (2017) | POSSIBILITIES OF IVABRADINE, A SELECTIVE INHIBITOR OF ION F-CHANNELS OF SINUS NODE, IN PREVENTION OF ANTHRACYCLINE CARDIOTOXICITY IN PATIENTS WITH BREAST CANCER | Abstract similar documents |
| Yu. V. Vasyuk, V. V. Nesvetov, E. L. Shkolnik, L. D. Shkolnik, G. V. Varlan, G. E. Gendlin, E. I. Emelina | ||
| "... Aim. To study the efficacy of ivabradine in the prevention of cardiotoxic effects due ..." | ||
| Vol 13, No 3 (2017) | SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES AMONG PATIENTS OF DIFFERENT AGE GROUPS WITH A HISTORY OF MYOCARDIAL INFARCTION BY THE EXAMPLE OF OUTPATIENT CARDIOLOGY INSTITUTION | Abstract similar documents |
| S. B. Fitilev, D. A. Dimitrova, I. I. Shkrebneva, A. V. Vozzhaev | ||
| "... Aim. To study secondary prevention of cardiovascular diseases among patients of different age ..." | ||
| Vol 9, No 4 (2013) | COMPARATIVE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS | Abstract similar documents |
| V. A. Sulimov, D. A. Napalkov, A. A. Sokolova | ||
| Vol 10, No 4 (2014) | NEW ORAL ANTICOAGULANTS: FOCUS ON THE SAFETY | Abstract similar documents |
| D. A. Napalkov, A. A. Sokolova | ||
| Vol 16, No 3 (2020) | Coronary Artery Disease with a High Risk of Complications: How to Identify Such Patients and Choose Management Tactics? | Abstract similar documents |
| S. G. Kanorskii | ||
| "... , and amputation. Secondary prevention in these high-risk patients should include control of modifiable risk ..." | ||
| Vol 9, No 5 (2013) | PRACTICAL APPLICATION OF DABIGATRAN ETEXILATE FOR STROKE PREVENTION IN PATIENTS WITH ATRIAL FIBRILLATION | Abstract similar documents |
| E. D. Kosmacheva, S. G. Kanorskiy, A. A. Kastanayan, N. V. Haylo, D. B. Goltyapin, E. A. Lipnitskaya, M. E. Statsenko | ||
| "... dabigatran etexilate, in the stroke prevention in patients with atrial fibrillation are considered. Factors ..." | ||
| Vol 10, No 6 (2014) | PHARMACOEPIDEMIOLOGIC ANALYSIS OF HOSPITAL TREATMENT OF PATIENTS WITH CEREBRAL INFARCTION AND ATRIAL FIBRILLATION | Abstract similar documents |
| N. V. Mikheeva, O. V. Reshetko, N. V. Furman | ||
| Vol 19, No 5 (2023) | Gender and age features of dyslipidemia in the population of the Nizhny Novgorod region | Abstract similar documents |
| N. Yu. Borovkova, V. K. Kurashin, A. S. Tokareva, T. E. Bakka, N. K. Pershina, E. S. Timoshchenko, A. A. Nekrasov, E. A. Ovchinnikova, N. N. Savickaya, M. A. Mironov, Yu. A. Balanova, A. E. Imaeva, A. V. Kontsevaya | ||
| "... risk and require the development of prevention and treatment measures for lipid metabolism disorders. ..." | ||
| Vol 20, No 1 (2024) | Prevention of complications during implantation of devices in arrhythmology, past, present and future | Abstract similar documents |
| O. R. Eshmatov, R. E. Batalov, S. N. Krivolapov, M. S. Khynin, E. S. Sitkova, L. A. Pokrovskaya, E. M. Berezina, V. V. Botvin | ||
| "... , these covers have become an effective method of prevention. New technologies of the envelopes promise to reduce ..." | ||
| Vol 9, No 3 (2013) | NICOTINE REPLACEMENT THERAPY OF THE TOBACCO ADDICTION IN PREVENTION OF CARDIORESPIRATORY DISEASES | Abstract similar documents |
| M. G. Gambaryan | ||
| "... of cardiorespiratory diseases. Smoking cessation is the most cost-effective measure for prevention of cardiovascular ..." | ||
| Vol 5, No 6 (2009) | ACETYLSALICYLIC ACID IN LOW DOSES FOR SECONDARY PREVENTION OF CARDIO-VASCULAR COMPLICATIONS | Abstract similar documents |
| N. A. Dmitrieva, S. N. Tolpygina | ||
| Vol 6, No 5 (2010) | THE INFECTIVE ENDOCARDITIS (PREVENTION, DIAGNOSIS CRITERIA AND TREATMENT): KEY POINTS 2010 | Abstract similar documents |
| A. A. Demin | ||
| "... Key positions of Guidelines on the prevention, diagnosis, and treatment of infective endocarditis ..." | ||
| Vol 11, No 3 (2015) | PHARMACOECONOMIC ASPECTS OF THE PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS AFTER LARGE JOINTS REPLACEMENT | Abstract similar documents |
| A. V. Rudakova | ||
| "... to patients’ death. The prevention of VTE events suggests the prescription of low molecular weight heparin ..." | ||
| Vol 10, No 6 (2014) | CONFERENCE “GENETIC TESTING AS A SOCIAL RESPONSIBILITY OF CITIZENS AND A DISABILITY PREVENTION” | Abstract similar documents |
| Vol 10, No 2 (2014) | PRIMARY PREVENTION OF MYOCARDIAL INFARCTION IN MIDDLE-AGED MALES (15-YEAR FOLLOW-UP): CLINICAL AND ECONOMIC ASPECTS OF THE PROBLEM | Abstract PDF (Eng) similar documents |
| A. M. Kalinina, A. V. Kontsevaya | ||
| "... -aged men during 15-year follow-up; to evaluate economic efficiency of primary medical prevention ..." | ||
| Vol 7, No 1 (2011) | SUPPRESSION OF RENIN-ANGIOTENSIN SYSTEM TO PREVENT COMPLICATIONS OF CARDIOVASCULAR DISEASES: CURRENT "ROLES" DISTRIBUTION FROM CLINICAL PHARMACOLOGIST’S POINT OF VIEW | Abstract similar documents |
| S. R. Gilyarevskiy, V. A. Orlov, M. V. Golshmid, G. Yu. Zakharova, I. I. Sinitsina | ||
| "... and prevention is discussed. Some large randomized clinical trials are analyzed. Physical and chemical properties ..." | ||
| Vol 7, No 6 (2011) | EXPERIENCE OF «SCHOOL OF HEALTH» AND A ROLE OF THE GENERAL PRACTITIONER IN THE STRUGGLE WITH RISK FACTORS OF ISCHEMIC HEART DISEASE | Abstract similar documents |
| N. M. Nurillaeva, A. G. Gadaev | ||
| Vol 11, No 1 (2015) | CHARACTERISTICS OF PATIENTS WITH CEREBRAL STROKE OR TRANSIENT ISCHEMIC ATTACK, INCLUDED INTO THE LIS-2 REGISTER (LYUBERTSY STUDY OF MORTALITY IN PATIENTS AFTER STROKE) | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, A. Yu. Suvorov, M. L. Ginzburg, A. D. Deev, S. A. Boytsov, A. V. Akimova, E. V. Daniels, N. A. Dmitrieva, L. Yu. Drozdova, N. Yu. Zhuravskaya, O. V. Lerman, Yu. V. Lukina, M. M. Loukianov, V. P. Smirnov, A. V. Fokina | ||
| "... of recurrent strokes indicates an underactive secondary prevention. ..." | ||
| Vol 11, No 1 (2015) | THE WAY OF ASSESSING THE ADHERENCE TO MODERN DRUG THERAPY CLINICAL GUIDELINES AIMED AT REDUCING THE RISK OF RECURRENT STROKE (ACCORDING TO THE LIS-2 REGISTER) | Abstract similar documents |
| A. Yu. Suvorov, S. Yu. Martsevich, N. P. Kutishenko, A. D. Deev, M. L. Ginzburg, A. V. Akimova, E. V. Daniels, N. A. Dmitrieva, L. Yu. Drozdova, N. Yu. Zhuravskaya, O. V. Lerman, Yu. V. Lukina, M. M. Loukianov, V. P. Smirnov, A. V. Fokina | ||
| "... Aim. To develop a method for the assessment of quality of medical prevention of recurrent stroke ..." | ||
| Vol 11, No 3 (2015) | EVALUATION OF THE CONFORMITY OF CARDIOVASCULAR THERAPY TO CURRENT CLINICAL GUIDELINES IN THE IMPROVEMENT OF OUTCOMES IN PATIENTS AFTER STROKE (ACCORDING TO THE LIS-2 REGISTER) | Abstract similar documents |
| A. Yu. Suvorov, S. Yu. Martsevich, N. P. Kutishenko, A. D. Deev, M. L. Ginzburg, A. V. Akimova, E. V. Daniels, A. V. Fokina, N. A. Dmitrieva, L. Yu. Drozdova, N. Yu. Zhuravskaya, O. V. Lerman, Yu. V. Lukina, M. M. Loukianov | ||
| "... for the prevention of recurrent stroke along with the prevention of recurrent ischemic attacks index (PRIA index ..." | ||
| Vol 14, No 6 (2018) | Evaluation of Drug Therapy and Adherence to It in Patients after Acute Coronary Syndrome in Real Clinical Practice (Results of One Year Observation) | Abstract PDF (Eng) similar documents |
| L. A. Khaisheva, S. E. Glova, V. A. Suroedov, A. S. Samakaev, S. V. Shlyk | ||
| Vol 19, No 2 (2023) | Secondary Prevention and Quality of Life of Patients with Stable Coronary Heart Disease | Abstract similar documents |
| E. D. Zharkova, Yu. V. Lukina, N. P. Kutishenko, E. T. Huseynova, N. P. Zolotareva, S. Yu. Martsevich, O. M. Drapkina | ||
| "... of prevention was also assessed, which included: (1) healthy lifestyle (healthy lifestyle) (rejection of bad ..." | ||
| Vol 7, No 2 (2011) | SUDDEN CARDIAC DEATH: ETIOLOGICY IN PATIENTS OF DIFFERENT AGES, RISK FACTORS AND PREVENTION | Abstract similar documents |
| O. V. Gaisenok | ||
| "... in different ages, risk factors and prevention. ..." | ||
| Vol 10, No 4 (2014) | OPTIMAL PREVENTION OF HOSPITAL VENOUS THROMBOEMBOLISM WITH THE HELP OF MEDICAL INFORMATION SYSTEM | Abstract similar documents |
| G. I. Nazarenko, S. A. Payushk, V. A. Otdelenov, E. B. Kleymenova, L. P. Yashina, D. A. Sychev | ||
| "... of clinical guidelines for the prevention of venous thromboembolic complications there is a gap between ..." | ||
| Vol 16, No 3 (2020) | The Value of Omega-3 Fatty Acids in the Prevention of Heart Rhythm Disorders | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova | ||
| "... ) in the prevention of heart rhythm disorders and the prevention of sudden cardiac death. In experimental studies ..." | ||
| Vol 4, No 3 (2008) | EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE FOURTH JOINT TASK FORCE OF THE EUROPEAN SOCIETY OF CARDIOLOGY AND OTHER SOCIETIES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE . | Abstract similar documents |
| I. Graham, D. Atar, K. Borch-Johnsen, G. Boysen, G. Burell, R. Cifkova, J. Dallongeville, G. De Backer, S. Ebrahim, B. Gjelsvik, C. Herrmann-Lingen, A. Hoes, S. Humphries, M. Knapton, J. Perk, S. G. Priori, K. Pyorala, Z. Reiner, L. Ruilope, S. Sans-Menendez, W. Scholte op Reimer, P. Weissberg, D. Wood, J. Yarnell, J. L. Zamorano | ||
| "... Society of Cardiology (ESC), в состав которого входят European Association for Cardiovascular Prevention ..." | ||
| Vol 4, No 4 (2008) | EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE (ENDING). FOURTH JOINT TASK FORCE OF THE EUROPEAN SOCIETY OF CARDIOLOGY AND OTHER SOCIETIES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE | Abstract similar documents |
| I. Graham, D. Ata, K. Borch-Johnsen, G. Boysen, G. Burell, R. Cifkova, J. Dallongeville, G. De Backe, Sh. Ebrahim, B. Gjelsvik, Ch. Herrmann-Lingen, A. Hoes, S. Humphries, M. Knapton, J. Perk, S. G. Priori, K. Pyorala, Z. Reiner, L. Ruilope, S. Sans-Menendez, W. Scholte op Reime, P. Weissberg, D. Wood, J. Yarnell, J. L. Zamorano | ||
| "... профилактике сердечно-сосудистых заболеваний в клинической практике. Приглашенные эксперты: Edmond Walma ..." | ||
| Vol 12, No 2 (2016) | ATRIAL FIBRILLATION: CURRENT PROBLEMS AND PROSPECTS OF MEDICAL CARE, TREATMENT AND PREVENTION | Abstract similar documents |
| Ju. P. Skirdenko, A. V. Shustov, V. V. Zherebilov, N. A. Nikolaev | ||
| "... outcomes, prevention of complications and long-term prognosis are ignored. Authors concluded ..." | ||
| Vol 6, No 6 (2010) | THE POSSIBILITIES OF ANTIARRHYTHMIC THERAPY IN PRIMARY PREVENTION OF DEATH IN PATIENTS WITH VENTRICULAR ARRHYTHMIAS | Abstract similar documents |
| Yu. A. Bunin | ||
| "... Highlights of primary prevention of death in patients with ventricular arrhythmias (VA ..." | ||
| Vol 6, No 6 (2010) | GUIDELINES ON THE PREVENTION, DIAGNOSIS, AND TREATMENT OF INFECTIVE ENDOCARDITIS (NEW VERSION 2009) | Abstract similar documents |
| Gilbert Habib, Bruno Hoen, Pilar Tornos, Franck Thuny, Bernard Prendergast, Isidre Vilacosta, Philippe Moreillon, Manuel de Jesus Antunes, Ulf Thilen, John Lekakis, Maria Lengyel, Ludwig Muller, Christoph K. Naber, Petros Nihoyannopoulos, Anton Moritz, Jose Luis Zamorano, M. O. Evseev | ||
| "... Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009). ..." | ||
| Vol 6, No 5 (2010) | GUIDELINES ON THE PREVENTION, DIAGNOSIS, AND TREATMENT OF INFECTIVE ENDOCARDITIS (NEW VERSION 2009) | Abstract similar documents |
| Gilbert Habib, Bruno Hoen, Pilar Tornos, Franck Thuny, Bernard Prendergast, Isidre Vilacosta, Philippe Moreillon, Manuel de Jesus Antunes, Ulf Thilen, John Lekakis, Maria Lengyel, Ludwig Muller, Christoph K. Naber, Petros Nihoyannopoulos, Anton Moritz, Jose Luis Zamorano, M. O. Evseev | ||
| "... Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009). ..." | ||
| Vol 11, No 1 (2015) | PHARMACOECONOMIC ASPECTS OF APIXABAN FOR PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION | Abstract similar documents |
| A. V. Rudakova | ||
| "... For prevention of thromboembolic events in patients with non-valvular atrial fibrillation (NVAF ..." | ||
| Vol 10, No 5 (2014) | STATINS IN THE TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES: REPETITION OF THE PAST AND OPTIMISM FOR THE FUTURE | Abstract similar documents |
| L. N. Malay | ||
| "... for the treatment and prevention of cardiovascular diseases caused by atherosclerosis. The milestones of lipid ..." | ||
| Vol 10, No 6 (2014) | NEXIUM. PREVENTION OF GASTRODUODENAL ULCER ASSOCIATED WITH NONSTEROIDAL ANTI-INFLAMMATORY DRUGS | Abstract similar documents |
| "... Nexium. Prevention of gastroduodenal ulcer associated with nonsteroidal anti-inflammatory drugs. ..." | ||
| Vol 11, No 5 (2015) | Cost-effectiveness of new oral anticoagulants in the treatment and secondary prevention of venous thromboembolism | Abstract similar documents |
| A. V. Rudakova | ||
| "... Aim. To assess the cost-effectiveness of apixaban in the treatment and secondary prevention ..." | ||
| Vol 1, No 3 (2005) | EDITORIAL COMMENTS ON “EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE” | Abstract similar documents |
| "... Editorial comments on “european guidelines on cardiovascular disease prevention in clinical ..." | ||
| Vol 8, No 4 (2012) | EFFECT OF CARDIOVASCULAR DRUGS ON BONE HEALTH AND THE POSSIBILITY OF THEIR USE FOR THE PREVENTION OF OSTEOPOROSIS | Abstract similar documents |
| I. A. Skripnikova, K. E. Sobchenko, O, V. Kosmatova, D. V. Nebieridze | ||
| "... to recommend discussed cardiovascular drugs for prevention of osteoporosis and fractures, as well ..." | ||
| Vol 8, No 2 (2012) | EFFICACY AND SAFETY OF ACETYLSALICYLIC ACID IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES | Abstract similar documents |
| S. N. Tolpygina, S. Yu. Martsevich, E. N. Khoseva, N. V. Kiseleva | ||
| "... Acetylsalicylic acid (ASA) use in the primary and secondary prevention of cardiovascular diseases ..." | ||
| Vol 2, No 2 (2006) | PECULIARITIES OF ARTERIAL HYPERTENSION DIAGNOSIS AND SECONDARY PREVENTION ACCORDING TO PHYSICIANS INTERVIEWING | Abstract similar documents |
| N. S. Oganisyan, N. A. Dmitrieva, A. M. Kochetkov, S. Y. Martsevich | ||
| "... blood pressure level below 140/90 mm Hg as target level of secondary prevention. Mainly antihypertensive ..." | ||
| Vol 2, No 3 (2006) | APPLICATION OF CALCIUM ANTAGONISTS IN PREVENTION OF CARDIOVASCULAR COMPLICATIONS DURING CARDIAC SURGERY | Abstract similar documents |
| S. V. Nedogoda | ||
| Vol 4, No 3 (2008) | COMMENTS ON EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE | Abstract similar documents |
| S. A. Shalnova | ||
| Vol 15, No 5 (2019) | Anticoagulant Therapy as a Tool for the Prevention of Cognitive Impairment Associated with Atrial Fibrillation | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov, S. P. Korchagina, T. M. Ostroumova, M. S. Chernyaeva, A. A. Kirichenko | ||
| "... as a drug that has a favorable efficacy profile for primary and secondary stroke prevention. Rivaroxaban ..." | ||
| Vol 18, No 3 (2022) | Coagulation Disorders in Infective Endocarditis: Role of Pathogens, Biomarkers, Antithrombotic Therapy (Systematic Review) | Abstract PDF (Eng) similar documents |
| A. S. Pisaryuk, V. A. Zamarashkina, N. B. Safarova, N. M. Povalyaev, E. O. Kotova, U. I. Babukhina, E. M. Koltsova, Zh. D. Kobalava | ||
| "... инфекционного эндокардита, ее влиянии на развитие эмболических осложнений, диагностика, лечение и профилактика ..." | ||
| Vol 18, No 4 (2022) | N-acetylcysteine in the Prevention of Contrast-induced Acute Kidney Injury: a Systematic Review and Meta-analysis of Randomized Controlled Clinical Trials | Abstract similar documents |
| E. M. Mezhonov, Yu. A. Vyalkina, S. V. Shalaev | ||
| "... такой терапии в качестве меры профилактики развития данного осложнения (отношение шансов 1,06, 95 ..." | ||
| Vol 18, No 6 (2022) | Predictors of Long-Term Outcomes after Surgical Myocardial Revascularization | Abstract similar documents |
| V. S. Kaveshnikov, M. A. Kuzmichkina, V. N. Serebryakova | ||
| "... the therapeutic targets of secondary prevention. Priority of arterial conduits and completeness ..." | ||
| Vol 19, No 1 (2023) | The Study of Adherence to Drug Therapy at the Stage of Outpatient Follow-up in Patients with Acute Myocardial Infarction (Data from the PROFIL-IM Registry) | Abstract similar documents |
| E. P. Kalaydzhyan, N. P. Kutishenko, Yu. V. Lukina, D. P. Sichinava, S. Yu. Martsevich, O. M. Drapkina | ||
| Vol 17, No 3 (2021) | Optimal Medical Therapy for Chronic Coronary Syndrome: Realities and Prospects | Abstract similar documents |
| P. A. Lebedev, I. K. Petrukhina, A. A. Garanin, E. V. Paranina | ||
| "... diseases in primary and secondary prevention in the Russian Federation, as evidenced by numerous registers ..." | ||
| Vol 5, No 4 (2009) | GASTROENTEROPATHIES ASSOCIATED WITH ACETYLSALICYLIC ACID: HOW TO IMPROVE SAFETY OF THERAPY | Abstract similar documents |
| A. L. Komarov | ||
| Vol 7, No 4 (2011) | GENDER DIFFERENCES IN THE EFFICACY OF RISK FACTORS CORRECTION AND TREATMENT COMPLIANCE IN PATIENTS AFTER ACUTE CORONARY SYNDROME | Abstract similar documents |
| A. Y. Efanov, D. F. Nizamova, E. F. Dorodneva, I. V. Medvedev, S. V. Shalaev | ||
| Vol 16, No 1 (2020) | Alirocumab Administration Experience to Achieve Low Density Lipoprotein Cholesterol Target Levels in Secondary Prevention of Cardiovascular Disease | Abstract similar documents |
| A. E. Nikitin, E. E. Averin, D. E. Rozhkov, A. V. Sozykin, G. A. Procenko | ||
| "... , alirocumab, on lipid levels in patients who receive secondary prevention of cardiovascular diseases (CVD ..." | ||
| Vol 16, No 2 (2020) | Clinical profile and drug therapy of outpatients with arterial hypertension | Abstract similar documents |
| N. V. Izmozherova, A. A. Popov, V. M. Bakhtin, M. A. Shambatov | ||
| Vol 16, No 3 (2020) | A Prospective, Initiative, Single-Center Open Post-Registration Comparative Study of Laboratory Efficacy of Various Forms of Acetylsalicylic Acid in a Cardioprotective Dose with Different Composition of Excipients: Results of the SFAIROS Study | Abstract similar documents |
| N. V. Lomakin, L. I. Buryachkovskaya, D. A. Zolin, V. I. Kazey | ||
| Vol 14, No 2 (2018) | FIVE-YEAR DYNAMICS OF SECONDARY PREVENTION IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED OUT-PATIENT LEVEL IN MOSCOW (PHARMACOEPIDEMIOLOGY STUDY) | Abstract similar documents |
| S. В. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, K. O. Tsukanova | ||
| "... prevention of cardiovascular diseases in patients with stable angina on the level of out-patient specialized ..." | ||
| Vol 16, No 5 (2020) | Untapped Possibilities of Antiischemic Therapy after Acute Myocardial Infarction: Data from the PROFILE-IM Register | Abstract similar documents |
| E. P. Kalaydzhyan, S. Yu. Martsevich, N. P. Kutishenko, D. P. Sichinava, O. M. Drapkina | ||
| Vol 17, No 2 (2021) | Features of Risk Stratification, Diagnosis and Secondary Prevention in Patients with Multifocal Arterial Disease. Part 2: Treatment Options | Abstract similar documents |
| V. G. Grachev, S. S. Vedenskaya, O. G. Smolenskaya | ||
| "... , regardless of their location, makes the approaches to secondary prevention similar, which include lifestyle ..." | ||
| Vol 17, No 1 (2021) | Features of Risk Stratification, Diagnosis and Secondary Prevention in Patients with Multifocal Arterial Disease. Part 1: Risk Stratification and Diagnosis | Abstract similar documents |
| V. G. Grachev, S. S. Vedenskaya, O. G. Smolenskaya | ||
| "... secondary prevention. According to observational studies, the presence of significant stenoses ..." | ||
| Vol 15, No 2 (2019) | Assessment of the Adequacy of Drug Choice in Patients with Acute Myocardial Infarction According to the PROFILE-IM Registry | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, E. P. Kalaydzhyan, D. P. Sichinava, V. A. Evdakov | ||
| Vol 18, No 2 (2022) | Changes in Long-term Mortality in Patients with Myocardial Infarction History According to the LIS Luberetskiy registry | Abstract PDF (Eng) similar documents |
| S. Y. Martsevich, N. P. Zolotareva, A. V. Zagrebelnyy, M. L. Ginzburg, O. M. Drapkina | ||
| 1 - 100 of 466 Items | 1 2 3 4 5 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
.jpg)
